Sign in

CIK 0002023658 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Bicara Therapeutics Inc.

Sign in to watch
Ticker
BCAX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-468-4219
Business address
116 HUNTINGTON AVENUE SUITE 703, BOSTON, MA, 02116
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 8-K Event Material agreement
  10. SCHEDULE 13G Stake Statement of Beneficial Ownership
  11. 10-Q Report Quarterly Report
  12. 8-K Event Results of operations
  13. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  14. ARS Other Annual Report to Security Holders
  15. DEFA14A Proxy Proxy Materials
  16. DEF 14A Proxy Proxy Statement
  17. S-8 Other Securities Offered to Employees in Benefit Plans
  18. 10-K Report Annual Report
  19. 8-K Event Results of operations
  20. 4 Planned sale Chief Legal Officer sold 79,146 shares at an average $12.90 ($1,021,211)

Page 10 of 14 · 266 filings